Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase NA 1Phase 1/2 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 14Head and Neck Neoplasms 11Glioblastoma 8Prostatic Neoplasms 7Carcinoma 6Rectal Neoplasms 5Pancreatic Neoplasms 5Gliosarcoma 5Carcinoma, Non-Small-Cell Lung 5Astrocytoma 5Neoplasm Metastasis 4Uterine Cervical Neoplasms 3Neoplasms 3Glioma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Medulloblastoma 2Lymphoma, Follicular 2Lymphoma 2Liver Neoplasms 2Leukemia, Myeloid, Acute 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Esophageal Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

Cetuximab 5Erlotinib Hydrochloride 3Radiotherapy 2Radiation 2Everolimus 2Docetaxel 2Cisplatin 2talactoferrin alfa 1mercaptoundecahydrododecaborate 1VTX-2337 1Taxes 1Sunitinib 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Pharmacogenomic Testing 1Microarray Analysis 1Lenalidomide 1Immunohistochemistry 1Hydroxyurea 1Gene Expression Profiling 1Fluorouracil 1Electrophoresis, Polyacrylamide Gel 1Chemotherapy, Adjuvant 1Carboplatin 1CBLB502 1Biopsy 1Albumin-Bound Paclitaxel 14-boronophenylalanine-fructose 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Tongue Neoplasms × Radiotherapy, Intensity-Modulated × Clear all
NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn
Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡